However, it was reported that lncRNA MAPT‐AS1 promotes the proliferation and migration of breast tumour cells through antisense pairing with MAPT, reducing the sensitivity of cancer cells to paclitaxel. This evidence concerns the gene MAPT and breast neoplasm.